Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 58 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Mirikizumab for treating moderately to severely active Crohn’s disease	Mirikizumab (LY3074828)	Crohn's disease	Gastroenterology , Immunology	2022	View \| Download
Nefecon (targeted-release budesonide formulation) for IgA Nephropathy (Berger's disease)	Budesonide targeted-release (Nefecon; PL-56)	IgA nephropathy	Immunology , Nephrology	2018	View \| Download
OTL-103 for Wiskott-Aldrich syndrome	OTL-103 (GSK-2696275)	Wiskott-Aldrich syndrome (WAS)	Genetic Disorders , Immunology	2020	View \| Download
Plinabulin in combination with G-CSF for chemotherapy-induced neutropenia	Plinabulin (BPI-2358)	Chemotherapy-induced neutropenia	Immunology , Toxicology	2020	View \| Download
Risankizumab for moderate to severe crohn’s disease	Risankizumab (BI 655066; Skyrizi; ABBV 066)	Crohn's disease	Gastroenterology , Immunology	2021	View \| Download
Ritlecitinib for alopecia areata	Ritlecitinib (PF-06651600)	Alopecia areata	Dermatology , Immunology	2021	View \| Download
Rituximab for Pemphigus Vulgaris	Rituximab (MabThera; Rituxan; RG 105)	Pemphigus vulgaris	Dermatology , Immunology	2018	View \| Download
Ruxolitinib for acute graft versus host disease (aGvHD)	Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate)	Graft versus host disease (GvHD)	Immunology	2019	View \| Download
Ruxolitinib for chronic graft versus host disease (cGvHD)	Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate)	Graft versus host disease (GvHD)	Immunology	2019	View \| Download
Sebetralstat for treating hereditary angioedema	Sebetralstat (KVD-900)	Hereditary angioedema (HAE)	Genetic Disorders , Immunology	2023	View \| Download